These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30716518)

  • 1. Blocking neuromuscular junctions with botulinum toxin A injection enhances neurological heterotopic ossification development after spinal cord injury in mice.
    Salga M; Tseng HW; Alexander KA; Jose B; Vaquette C; Debaud C; Gatin L; Genêt F; Levesque JP
    Ann Phys Rehabil Med; 2019 May; 62(3):189-192. PubMed ID: 30716518
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum Toxin-induced Muscle Paralysis Inhibits Heterotopic Bone Formation.
    Ausk BJ; Gross TS; Bain SD
    Clin Orthop Relat Res; 2015 Sep; 473(9):2825-30. PubMed ID: 25804882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypertonia on contracture development in rat spinal cord injury.
    Moriyama H; Ozawa J; Yakuwa T; Inoue S; Wakigawa T; Kito N; Sakai Y; Akisue T
    Spinal Cord; 2019 Oct; 57(10):850-857. PubMed ID: 31201373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Applications of botulinum toxin in Neurology].
    Garcia-Ruiz PJ
    Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral denervation participates in heterotopic ossification in a spinal cord injury model.
    Debaud C; Salga M; Begot L; Holy X; Chedik M; de l'Escalopier N; Torossian F; Levesque JP; Lataillade JJ; Le Bousse-Kerdilès MC; Genêt F
    PLoS One; 2017; 12(8):e0182454. PubMed ID: 28854256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle.
    Harrison AR; Berbos Z; Zaldivar RA; Anderson BC; Semmer M; Lee MS; McLoon LK
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):982-6. PubMed ID: 21087967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic success with local botulinum toxin in erythromelalgia.
    da Costa AF; Meireles J; Festas MJ; Gomes A; Abreu P
    Pain Physician; 2014; 17(5):E658-60. PubMed ID: 25247918
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on dose conversion ratio between two botulinum toxin A preparations when injected in the sweat glands.
    Zakine B
    Am J Clin Dermatol; 2009; 10(5):347; author reply 347-8. PubMed ID: 19757543
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin B increases intrinsic muscle activity in organotypic spinal cord-skeletal muscle co-cultures.
    Eckle VS; Balk M; Thiermann H; Antkowiak B; Grasshoff C
    Toxicol Lett; 2016 Feb; 244():167-171. PubMed ID: 26260118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effects of intradetrusor botulinum toxin injections on ejaculation and fertility in men with spinal cord injury: preliminary findings.
    Caremel R; Courtois F; Charvier K; Ruffion A; Journel NM
    BJU Int; 2012 Jun; 109(11):1698-702. PubMed ID: 21981647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders.
    de Maio M
    Expert Opin Biol Ther; 2008 Jun; 8(6):791-8. PubMed ID: 18476790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA; Song DH; Oh HM; Chung ME
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of crotoxin on the induction of paralysis in extraocular muscle in animal model.
    Ribeiro Gde B; Almeida HC; Velarde DT; Sá ML
    Arq Bras Oftalmol; 2012 Oct; 75(5):307-12. PubMed ID: 23471322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mouse model of spinal cord injury-induced heterotopic ossification.
    Kang H; Dang AB; Joshi SK; Halloran B; Nissenson R; Zhang X; Li J; Kim HT; Liu X
    J Rehabil Res Dev; 2014; 51(7):1109-18. PubMed ID: 25436890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globular chitosan prolongs the effective duration time and decreases the acute toxicity of botulinum neurotoxin after intramuscular injection in rats.
    Sergeevichev DS; Krasilnikova AA; Strelnikov AG; Fomenko VV; Salakhutdinov NF; Romanov AB; Karaskov AM; Pokushalov EA; Steinberg JS
    Toxicon; 2018 Mar; 143():90-95. PubMed ID: 29371111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
    Cai BB; Francis J; Brin MF; Broide RS
    Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
    Smith CP; Gangitano DA; Munoz A; Salas NA; Boone TB; Aoki KR; Francis J; Somogyi GT
    Neurochem Int; 2008 May; 52(6):1068-75. PubMed ID: 18187233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.
    Chen SF; Chang CH; Kuo HC
    Spinal Cord; 2016 Oct; 54(10):889-894. PubMed ID: 26832760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlabeled uses of botulinum toxins: a review, part 2.
    Cheng CM; Chen JS; Patel RP
    Am J Health Syst Pharm; 2006 Feb; 63(3):225-32. PubMed ID: 16434781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.